This post is sponsored by IMARC Research, Inc. Since the August 2011 release of the draft guidance document by the FDA on a risk-based approach to monitoring, there has been a lot of buzz in the ...
The U.S. Food and Drug Administration (FDA) recently finalized its guidance, “A Risk-Based Approach to Monitoring of Clinical Investigations” (the “2023 RBM Guidance”) which follows up on the Agency’s ...
Publisher's note: This material was paid for by CCS Medical and provided by CCS Medical. The views expressed by the author are their own. This material is not part of Health Affairs Forefront; it has ...
Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions. For ...
Bethesda, MD (Oct. 17, 2025) — The American Gastroenterological Association (AGA) today released a new clinical practice guideline on the surveillance of Barrett's esophagus, the only known precursor ...
Risk-sharing agreements incentivize high-quality diabetes care by linking reimbursement to value-based outcomes, addressing social determinants of health. Continuous glucose monitoring (CGM) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results